SCHEMBL27896447

SCHEMBL27896447

CC(C)(C)OC1CC(NC=O)N(C2(C=O)CCC2)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20103869 0.64 ADH1B (0.41) —
SCHEMBL15705874 0.57 — —
SCHEMBL17106593 0.56 — —
SCHEMBL9005336 0.56 — —
SCHEMBL13337538 0.56 — —
SCHEMBL13684693 0.56 — —
SCHEMBL9675535 0.55 — —
SCHEMBL14596219 0.54 NR1H2 (0.30) —
SCHEMBL15705878 0.54 — —
SCHEMBL22556979 0.54 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102791693-B Hepatitis c virus inhibitors BRISTOL-MYERS SQUIBB CO. (US) 2016-04-13 — — CN claimed
CN-102791693-A Hepatitis c virus inhibitors BRISTOL MYERS SQUIBB CO 2012-11-21 — — CN claimed
Send feedback